Chapter 1 20 51. Ferrari P. The role of 11β-hydroxysteroid dehydrogenase type 2 in human hypertension. Biochim Biophys Acta - Mol Basis Dis. 2010. doi:10.1016/j.bbadis.2009.10.017 52. Schnackenberg CG, Costell MH, Krosky DJ, et al. Chronic inhibition of 11 β -hydroxysteroid dehydrogenase type 1 activity decreases hypertension, insulin resistance, and hypertriglyceridemia in metabolic syndrome. Biomed Res Int. 2013. doi:10.1155/2013/427640 53. Takaya J, Iharada A, Okihana H, Kaneko K. Down-regulation of hepatic phosphoenolpyruvate carboxykinase expression in magnesium-deficient rats. Magnes Res. 2012;25(3):131-139. doi:10.1684/mrh.2012.0321 54. Takaya J, Iharada A, Okihana H, Kaneko K. Magnesium deficiency in pregnant rats alters methylation of specific cytosines in the hepatic hydroxysteroid dehydrogenase-2 promoter of the offspring. Epigenetics. 2011;6(5):573-578. doi:10.4161/epi.6.5.15220 55. Thomas AE, Inagadapa PJN, Jeyapal S, Merugu NM, Kalashikam RR, Manchala R. Maternal Magnesium Restriction Elevates Glucocorticoid Stress and Inflammation in the Placenta and Fetus of WNIN Rat Dams. Biol Trace Elem Res. 2018;181(2):281-287. doi:10.1007/s12011-0171058-3 56. Blaine J, Chonchol M, Levi M. Renal control of calcium, phosphate, and magnesium homeostasis. Clin J Am Soc Nephrol. 2015. doi:10.2215/CJN.09750913 57. Joosten MM, Gansevoort RT, Mukamal KJ, et al. Urinary and plasma magnesium and risk of ischemic heart disease. Am J Clin Nutr. 2013;97(6):1299-1306. doi:10.3945/ajcn.112.054114 58. Chiuve SE, Korngold EC, Januzzi JLJ, Gantzer M Lou, Albert CM. Plasma and dietary magnesium and risk of sudden cardiac death in women. Am J Clin Nutr. 2011;93(2):253-260. doi:10.3945/ ajcn.110.002253 59. Akarolo-Anthony SN, Jiménez MC, Chiuve SE, Spiegelman D, Willett WC, Rexrode KM. Plasma magnesium and risk of ischemic stroke among women. Stroke. 2014. doi:10.1161/ STROKEAHA.114.005917 60. Huijgen HJ, Van Ingen HE, Kok WT, Sanders GTB. Magnesium fractions in serum of healthy individuals and CAPD patients, measured by an ion-selective electrode and ultrafiltration. Clin Biochem. 1996. doi:10.1016/0009-9120(96)84729-B 61. Ordak M,Maj-Zurawska M,Matsumoto H, et al. Ionized magnesium in plasma and erythrocytes for the assessment of low magnesium status in alcohol dependent patients. Drug Alcohol Depend. 2017. doi:10.1016/j.drugalcdep.2017.04.035 62. Saris NE, Mervaala E, Karppanen H, Khawaja JA, Lewenstam A. Magnesium. An update on physiological, clinical and analytical aspects. Clin Chim Acta. 2000;294(1-2):1-26. 63. Zhan J,Wallace TC, Butts SJ, et al. Circulating ionized magnesium as a measure of supplement bioavailability: Results from a pilot study for randomized clinical trial. Nutrients. 2020. doi:10.3390/nu12051245 64. Arnaud MJ. Update on the assessment of magnesium status. Br J Nutr. 2008;99(S3):S24-S36. doi:10.1017/S000711450800682X 65. Ulger Z, Ariogul S, Cankurtaran M, et al. Intra-erythrocyte magnesium levels and their clinical implications in geriatric outpatients. J Nutr Heal Aging. 2010. doi:10.1007/s12603-010-0121-y 66. Deuster PA, Trostmann UH, Bernier LL, Dolev E. Indirect vs direct measurement of magnesium and zinc in erythrocytes. Clin Chem. 1987;33(4):529-532.
RkJQdWJsaXNoZXIy MTk4NDMw